The Latest Nutraceuticals Articles from Streetwise Reports


News Update

Maker of Antibiotic-Free Animal Supplement Lands First Order from Mexico

News Update
  ()
This new market is a significant one for Avivagen. read more >
News Update

Avivagen to Be Featured on BioPub Webcast Hosted by Dr. KSS MD PhD on March 6

News Update
  ()
Webcast will be at 12 noon ET on Friday, March 6. read more >
News Update

Antibiotic-Free Feed Additive Shows Benefit in Cow Mastitis Trial

News Update
  ()
Avivagen's proprietary product yielded statistically significant results. read more >
News Update

CEO Reviews Life Sciences Firm's Year of 'Exceptional Accomplishment'

News Update
  ()
The company makes progress getting its products approved and sold in more countries. read more >
News Update

Life Sciences Firm Upgrades to OTCQB Venture Market

News Update
  ()
This is a significant achievement of this developing company. read more >
News Update

Agreement Sets Stage to Secure Chinese Approval of Non-Antibiotic Livestock Feed Supplement

News Update
  ()
The requirements include, among others, trials of the company's livestock feed additive. read more >
News Update

Feed Additive Developer Signs MOU with Philippine Distributor

News Update
  ()
This is the first step toward a binding, definitive agreement between the two companies. read more >
News Update

Animal Health Product Developer Lands First Sale in Malaysia

News Update
  ()
The maiden order comes on the heels of the country approving use of the product there. read more >

Coverage Initiated on Maker of Antibiotic-Free Supplement for Livestock Feed

Research Report
  ()
The highlights of this investment story are outlined in a Zacks Small-Cap Research report. read more >

Technical Analyst: As Antibiotic Resistance Rises, So May the Stock of This Livestock Feed Company

Contributed Opinion
  ()
Technical analyst Clive Maund believes this stock could gain traction soon. read more >
Showing Results: 1 to 10 of 10

Get Our Streetwise Reports Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe

More Experts